
|
FACT SHEET
The Biologic Cause of the Abortion
Breast Cancer Link: The Physiology of the Breast
May, 2003
The physiology of the breast provides the
strongest evidence of the causal link between
abortion and breast cancer. The same biology
that accounts for 90% of all risk factors
for breast cancer accounts for the ABC link.
Simply stated, the biology rests on two
principles.
1.
The more estrogen a woman is exposed to
in her lifetime, the higher her risk for
breast cancer. It is well established that
estrogen is implicated in the formation
of three cancers: uterine, germ cell and
breast.1 Estrogen
can induce cancers to form in two ways,
as a genotoxin and a mitogen. A genotoxin
or mutagen directly damages the DNA (causes
mutations), initiating a process that leads
to the formation of cancer cells. Certain
natural metabolites of estrogen have been
shown to cause mutations.2
A mitogen causes cells
to proliferate, that is, to multiply through
division (mitosis). Each a time a cell divides
to form two cells, it must replicate its
DNA. During replication, mutations in the
form of copying errors and/or chromosomal
translocations can occur, causing abnormal
cells to form. These abnormal cells can
go on to become cancerous. The stimulation
of proliferation (mitogenesis) that estrogen
causes, increases the chances that abnormal
cells will grow into malignant tumors. Estrogen
is so potent that it is measured in parts
per trillion.
If a woman starts her menstrual cycles
early, say, age nine and continues to menstruate
into her late 50's, she is at higher risk
for breast cancer, as she has been exposed
to monthly estrogen elevations for a long
period of time. This too is the science
behind a recent, well-publicized study that
shows that estrogen-based hormone replacement
therapy increases the risk of breast cancer.3
In a similar way,
birth control pills can elevate breast cancer
risk.
2.
The earlier a woman's breast matures from
prepubescent (Type 1) and pubescent (Type
2) lobules to reproductive (Type 3) and
lactation (Type 4) lobules (see diagrams),
the lower her risk of breast cancer.4
Type 1 and 2 lobules
are known to be where cancers arise, in
the TDLUs (terminal ductal lobular units),5
whereas Type 3 and
4 lobules are mature and resistant to carcinogens.
When a female child is born, she has only
a small number of primitive Type 1 lobules.
At puberty, when estrogen levels rise, the
breast forms Type 2 lobules. It is only
through the hormonal environment and length
of a full term (or to at least 32 weeks)
pregnancy that there is full maturation
of Type 3 and 4 lobules in the breast. This
maturation protects a woman and lowers her
risk of breast cancer.
This is why women who undergo full term
pregnancies have lower risk of breast cancer
and why women who remain childless have
higher risk of breast cancer. Women who
give birth after age 30 are also at increased
risk of breast cancer as their immature
Type 1 and 2 lobules are exposed to estrogen
for the many years between the time of their
first menstruation until their first full
term pregnancy. Abortion in women under
18 and over 30 years old carries the greatest
risk: these women have the highest percentage
of Type 1 lobules in their breasts.
It is the interplay of these two principles,
estrogen exposure and breast lobule maturation,
which accounts for the fact that abortion
can lead to breast cancer. Within a few
days of conception, a woman's estrogen level
rises. By the end of the first trimester,
estrogen levels have increased by 2000%.
The estrogen stimulation that causes the
multiplication of Type 1 and 2 lobules,
results in sore and tender breasts early
on in pregnancy. It is only after 32 weeks
that a woman's breasts stop growing larger
and mature into Type 3 and 4 lobules in
preparation for breast-feeding.
If abortion ends a woman's pregnancy before
full maturation of her breasts, she is left
with an increased number of the immature
Type 1 and 2 lobules. She now has a greater
number of the breast lobules where cancers
can arise. This causes her to be at greater
risk for breast cancer. It is through this
same biologic mechanism that any premature
birth before 32 weeks more than doubles
breast cancer risk.
Induced abortion thus increases breast cancer
risk by two mechanisms. First, abortion
leaves the breast with increased numbers
of Type 1 and Type 2 lobules, those lobules
in which cancer cells are formed, which
are then exposed to more estrogen through
menstrual cycles. These lobules would otherwise
have been protected from cancer by maturation
to Type 3 and 4 lobules, if pregnancy had
gone to term. Second, the breast is exposed
to high levels of estrogen during pregnancy,
which can induce cancer cells to form.
6
|
|
Types of Breast Lobules
|
|
|
|
| Diagrams taken from
Schwartz, Shires, Spencer, eds., Principles of
Surgery 5th Ed. (McGraw Hill, 1989) |
1. Henderson BE, Ross R, Bernstein
L. Estrogen is a cause of human cancer: The Richard
and Hilda Rosenthal Foundation Award Lecture. Cancer
Research 1988;48:246-53.
Back to document
2. Miller, Katherine. Estrogen
and DNA damage: The silent source of breast cancer?
J Natl Cancer Inst 2003: 95:100-102.
Back to document
3. Writing group for the Women's
Health Initiative Investigators. Risks and benefits
of estrogen plus progestin in healthy postmenopausal
women. JAMA 2002;288:321-33.
Back to document
4. Diagrams taken from eds. Schwartz,
Shires, Spencer, Principles of Surgery (McGraw Hill)
Russo J, Tay LK, Russo IH. Differentiation of the
mammary gland and susceptibility to carcinogenesis.
Breast Cancer Res & Treatment 1982;2:5-73.
Back to document
5. Daling JR, Malone DE, Voigt
LF, White E, Weiss NS. Risk of breast cancer among
young women: relationship to induced abortion. J Natl
Cancer Inst 1994;86:1584-92.
Back to document
6. Melbye M, et al. Preterm delivery
and risk of breast cancer. Brit J Cancer 1999;80:609.
Pregnancies that result in first trimester spontaneous
abortions produce subnormal estrogen concentrations
and generally do not increase breast cancer risk.
That is, there is little estrogen stimulation of the
breast. Stewart DR, Overstreet JW, Nakajima ST, Lasley
BL. Enhanced ovarian steroid secretion before implantation
in early human pregnancy. J Clin Endocrinol Metab
1993;76:1470-6. Kunz J, Keller PJ. HCG, HPL, oestradiol,
progesterone and AFP in serum in patients with threatened
abortion. Br J Obstet Gynaecol 1976;83:640-4. Witt
BR, Wolf GC, Wainwright CJ, Johnston PD, Thorneycroft
IH. Relaxin, CA-125, progesterone, estradiol, Schwangerschaft
protein, and human chorionic gonadotropin as predictors
of outcome in threatened and non-threatened pregnancies.
Fertil Steril 1990;53:1029-36. Norman RJ, McLoughlin
JW, Borthwick GM, Yohkaichiya T, Matthews CD, MacLennan
AH, de Kretser DM. Inhibin and relaxin concentrations
in early singleton, multiple, and failing pregnancy:
relationship to gonadotropin and steroid profiles.
Fertil Steril 1993;59:130-7
Back to document
|
 |